[Effect of imidazoline receptor agonist moxonidine on the state of microcirculation and renal function in patients with hypertension and diabetes mellitus type 2].
Trusov
V V
VV
Izhevsk State Medical Academy, Russia.
Aksenov
K V
KV
D000959:Antihypertensive Agents / Q000494:pharmacology* / Q000627:therapeutic use; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000503:physiopathology*; D003928:Diabetic Nephropathies / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology*; D005260:Female; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology*; D007093:Imidazoles / Q000494:pharmacology* / Q000627:therapeutic use; D007668:Kidney / Q000098:blood supply / Q000187:drug effects / Q000503:physiopathology*; D008297:Male; D008833:Microcirculation / Q000187:drug effects*; D008875:Middle Aged; D016896:Treatment Outcome
D000959:Antihypertensive Agents; D007093:Imidazoles; C043482:moxonidine